
|Articles|May 1, 2003
Consider efficacy, effectiveness, safety to prove all-around value of a drug
Author(s)Mari Edlin
FMCP model urges plans to think outside the cost silo when making formulary decisions
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement























